Pharma Journalist 9038 posts 0 comments

Recursion announced it has entered into a global licensing agreement with Takeda Pharmaceutical Company Limited (Takeda) to gain rights to TAK-733, a clinical-stage MEK inhibitor, and…
Read More...

Neuraptive Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for its franchise therapeutic product, NTX-001, in the…
Read More...

Evonik announced the successful commissioning of an advanced biomaterials facility in Birmingham, USA that will support the increasing global market demand for the use of RESOMER…
Read More...

Catalent announced a collaboration with Ennaid Therapeutics to develop an oral, antiviral treatment targeted at COVID-19. Under the terms of the agreement, Catalent will develop a…
Read More...

Boehringer Ingelheim and CDR-Life announced they have entered into a collaboration and licensing agreement to research and develop antibody fragment-based therapeutics for geographic…
Read More...

We are excited to release the digital event agenda for the Innate Immune Stimulating Therapies Summit, taking place on Wednesday, July 22. Download your copy here. Join the…
Read More...

BioMed X, an independent research institute that identifies big biomedical research challenges and provides innovative solutions by combining global crowdsourcing with local incubation,…
Read More...

Cipla Limited announced that it has signed a non-exclusive licensing agreement with Gilead Sciences, Inc. for the manufacturing and distribution of the investigational medicine…
Read More...

CytoAgents announced that it has been awarded a National Institutes of Health (NIH) grant to accelerate the development of its lead drug candidate, GP1681, an investigational new drug…
Read More...

Skyhawk Therapeutics, Inc. announced that it has expanded its strategic collaboration with Merck, known as MSD outside the United States and Canada, to discover, develop and…
Read More...